Status:
COMPLETED
Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Collaborating Sponsors:
Kali Care
Conditions:
Corneal Graft Disorder (Disorder)
Corticosteroid
Eligibility:
All Genders
18+ years
Brief Summary
Following corneal graft, local steroids with a gradually decreasing dose for 12 months are prescribed to reduce the graft rejection risk (maximum incidence of 20% for the first 12 months). The validat...
Eligibility Criteria
Inclusion
- Newly transplanted corneal patients
- Patients able to instill correctly topical corticosteroid treatment
- Patients able to come to control visits
- Patient affiliated or entitled to a social security system
- Patient informed about the study and having signed a consent
Exclusion
- Patients under guardianship
- Patients unable to give their consent or to correctly use the collection box
Key Trial Info
Start Date :
November 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 22 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04107246
Start Date
November 20 2019
End Date
October 22 2021
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Saint Etienne
Saint-Etienne, France, 42055